David graduated from the University of Glasgow in 2013 with a First Class Masters Degree (MEng) in Electronic and Electrical Engineering and was awarded the Lamb Master of Engineering Prize as the highest achieving MEng student in the final two years of study. During his time on the undergraduate course, he completed a 6-month placement at CERN, where he successfully designed a module which is responsible for monitoring the temperature of various electronic components on the large hadron collider.
From 2013-2017, David pursued a PhD in III-V compound semiconductor MOS technology, also at the University of Glasgow. During this time, he developed a world leading III-V junctionless MOSFET and presented his work at 4 international conferences.
Following his PhD, David was employed as a Postdoctoral Research Assistant working on antimonide MOSFETs as part of the INSIGHT collaboration: an EU funded project with partners from both academia and industry and a total budget of €4.25 million.
Electrical and Electronics Engineering, University of Glasgow
Novel III-V MOS Technologies for Low Power Digital Logic Applications, University of Glasgow
Awarded annually to the fifth year student in the MEng course in the Department of Electronics and Electrical Engineering, who has achieved the best overall performance in the final two years of the course.
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.